FDA Inspection
Zhejiang Raybow Pharmaceutical Co., Ltd.Zhejiang Raybow Pharmaceutical Co., Ltd. – FDA Inspection, Jul 11, 2019
Record Details
This FDA Inspection record concerns Zhejiang Raybow Pharmaceutical Co., Ltd., with an inspection on July 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e0890c9e-f2cb-4fb8-b257-6c695dc09031
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096223
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Raybow Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 22, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Raybow Pharmaceutical Co., Ltd.
- FDA Inspection 1256688 - 2024-11-01
- FDA Inspection 976084 - 2016-04-22
- FDA Inspection 878238 - 2014-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.